Dazdotuftide: Novel Treatment for Noninfectious Uveitis with Superior Intraocular Pressure Safety Profile: A Randomized Clinical Trial

20260 citationsJournal Articlehybrid Open Access

Authors

David S. Chu · Rutgers, The State University of New Jersey

Edmund Tsui · University of California, Los Angeles

Lana M. Rifkin · Ophthalmic Consultants of Boston

Alan G. Palestine · University of Colorado Denver

Cadmus Rich · Mapi Pharma (Israel)

Jennifer E. Thorne · Johns Hopkins University

Daphne Haim-Langford

Abstract

TRS01 offers the potential to serve as an effective and safe treatment option in NIU that meets the urgent need for a drug that controls inflammation without the steroids' associated risk of IOP elevation.

Topics & Keywords

Ocular Diseases and Behçet’s Syndrome IgG4-Related and Inflammatory Diseases Sarcoidosis and Beryllium Toxicity Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Ophthalmology

Volume 284, pp. 78-87

DOI: 10.1016/j.ajo.2025.12.034

Field-Weighted Citation Impact: 0.00